Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 62, Issue 20, Pages 9315-9330Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.9b01340
Keywords
-
Categories
Funding
- Conselleria de Cultura, EducaciOn e Ordenacion Universitaria of the Galician Government [ED431B2017/70]
- Centro Singular de InvestigaciOn de Galicia accreditation [ED431G/09]
- European Regional Development Fund (ERDF), the Swedish Research Council
- Swedish strategic research program eSSENCE
- European COST action ERNEST [CA 18133]
Ask authors/readers for more resources
We report the identification of two subsets of fluorinated nonxanthine A(2B) adenosine receptor antagonists. The novel derivatives explore the effect of fluorination at different positions of two pyrimidine-based scaffolds. The most interesting ligands combine excellent hA(2B) affinity (K-i < 15 nM) and remarkable subtype selectivity. The results of functional cAMP experiments confirmed the antagonistic behavior of representative ligands. The compounds were designed on the basis of previous molecular models of the stereoselective binding of the parent scaffolds to the hA(2B) receptor, and we herein provide refinement of such models with the fluorinated compounds, which allows the explanation of the spurious effects of the fluorination at the different positions explored. These models are importantly confirmed by a synergistic study combining chiral HPLC, circular dichroism, diastereoselective synthesis, molecular modeling, and X-ray crystallography, providing experimental evidence toward the stereospecific interaction between optimized trifluorinated stereoisomers and the hA(2B) receptor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available